Stuart Anderson, "Pharmacopoeias, Drug Regulation, and Empires: Making Medicines Official in Britain's Imperial World, 1618-1968" (McGill-Queen's UP, 2024)

episode

New Books in Drugs, Addiction and Recovery not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

More from New Books in Drugs, Addiction and Recovery

Ben Westhoff ed.,"Lives Interrupted: The Fentanyl Tragedy" (Arsenault Family Foundation, 2026) 27 min · 09 Sep 2026

All episodes from New Books in Drugs, Addiction and Recovery →

Report any issue

Source

Recorded06 Nov 2024

Publisherfeeds.megaphone.fm

Handlerec:5380983

Show notes

The word "pharmacopoeia" has come to have many meanings, although it is commonly understood to be a book describing approved compositions and standards for drugs. In 1813 the Royal College of Physicians of London considered a proposal to develop an imperial British pharmacopoeia - at a time when separate official pharmacopoeias existed for England, Scotland, and Ireland. A unified British pharmacopoeia was published in 1864, and by 1914 it was considered suitable for the whole Empire. Pharmacopoeias, Drug Regulation, and Empires: Making Medicines Official in Britain's Imperial World, 1618-1968 (McGill-Queen's University Press, 2024) by Dr. Stuart Anderson traces the 350-year development of officially sanctioned pharmacopoeias across the British Empire, first from local to national pharmacopoeias, and later to a standardised pharmacopoeia that would apply throughout Britain’s imperial world. The evolution of British pharmacopoeias and the professionalisation of medicine saw developments including a transition from Galenic principles to germ theory, and a shift from plant-based to chemical medicines. While other colonial powers in Europe usually imposed metropolitan pharmacopoeias across their colonies, Britain consulted with practitioners throughout its Empire. As the scope of the pharmacopoeia widened, the process of agreeing upon drug standardisation became more complex and fraught. A wide range of issues was exposed, from bioprospecting and the inclusion of indigenous medicines in pharmacopoeias, to adulteration and demands for the substitution of pharmacopoeial drugs with locally available ones. Pharmacopoeias, Drug Regulation, and Empires uses the evolution of an imperial pharmacopoeia in Britain as a vehicle for exploring the hegemonic power of European colonial powers in the medical field, and the meaning of pharmacopoeia more broadly. This interview was conducted by Dr. Miranda Melcher whose new book focuses on post-conflict military integration, understanding treaty negotiation and implementation in civil war contexts, with qualitative analysis of the Angolan and Mozambican civil wars. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/drugs-addiction-and-recovery

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.